These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 12132349
1. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus]. Perusicová J, Bárová H, Hill M, Masek Z. Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349 [Abstract] [Full Text] [Related]
2. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A]. Martinka E, Ocenásová A, Straková J, Mokán M. Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228 [Abstract] [Full Text] [Related]
3. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin]. Pánczél P, Hosszúfalusi N, Bornemisza B, Horváth L, Jánoskuti L, Füst G, Rajczy K, Vatay A, Prohászka Z, Madácsy L, Luczay A, Blatniczky L, Halmos T, Körner A, Szilvási I, Romics L. Orv Hetil; 2001 Nov 18; 142(46):2571-8. PubMed ID: 11770176 [Abstract] [Full Text] [Related]
4. [Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: study of 308 patients]. Zhang C, Zhou ZG, Lin J, Huang G, Wang JP, Zhang DM, Zhou M, Yang XL. Zhonghua Yi Xue Za Zhi; 2008 Mar 25; 88(12):797-801. PubMed ID: 18756979 [Abstract] [Full Text] [Related]
5. [Glutamic acid decarboxylase autoantibodies (antiGAD-Ab) in patients with non-insulin dependent diabetes mellitus (NIDDM)]. Martinka E, Straková J, Ocenásová A, Pullmannová D, Petrisková J, Mácková N, Sutarík L, Galajda P, Baláz D, Kerný J, Vladár L, Mokán M. Vnitr Lek; 1998 Jan 25; 44(1):17-22. PubMed ID: 9750478 [Abstract] [Full Text] [Related]
6. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients]. Reinsch B, Zimmy S, Schatz H, Pfohl M. Med Klin (Munich); 2003 Feb 15; 98(2):67-71. PubMed ID: 12601530 [Abstract] [Full Text] [Related]
7. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G. Diabet Med; 2004 May 15; 21(5):456-9. PubMed ID: 15089790 [Abstract] [Full Text] [Related]
8. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis. Katz LE, Jawad AF, Ganesh J, Abraham M, Murphy K, Lipman TH. Pediatr Diabetes; 2007 Apr 15; 8(2):53-9. PubMed ID: 17448127 [Abstract] [Full Text] [Related]
9. The value of basal C peptide and its relationship with pancreatic autoantibodies in young adults with type 2 diabetes mellitus. Vlad A, Serban V, Sima A, Timar R, Roşu M. Rom J Intern Med; 2004 Apr 15; 42(2):333-41. PubMed ID: 15529624 [Abstract] [Full Text] [Related]
10. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Lindholm E, Hallengren B, Agardh CD. Diabetes Metab Res Rev; 2004 Apr 15; 20(2):158-64. PubMed ID: 15037992 [Abstract] [Full Text] [Related]
12. [C-peptide determination in diabetics for the evaluation of insulin requirements]. Keller U, Pasquel M, Berger W. Schweiz Med Wochenschr; 1987 Feb 07; 117(6):187-92. PubMed ID: 3551060 [Abstract] [Full Text] [Related]
13. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers. Amrouche Ch, Jamoussi Kamoun H, Trabelsi N, Blouza Chabchoub S. Tunis Med; 2008 Apr 07; 86(4):316-8. PubMed ID: 19476130 [Abstract] [Full Text] [Related]
15. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes. Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE. J Autoimmun; 2005 Mar 07; 24(2):153-67. PubMed ID: 15829408 [Abstract] [Full Text] [Related]
16. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus. Serban V, Enache A, Vlad A, Sima A, Roşu M, Roşca A, Drăghici C. Rom J Intern Med; 2004 Mar 07; 42(2):325-32. PubMed ID: 15529623 [Abstract] [Full Text] [Related]
17. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults. Yang L, Zhou ZG, Tan SZ, Huang G, Jin P, Yan X, Li X, Peng H, Hagopian W. Ann N Y Acad Sci; 2008 Dec 07; 1150():263-6. PubMed ID: 19120309 [Abstract] [Full Text] [Related]
18. Clinical characteristics in the discrimination between patients with low or high C-peptide level among middle-aged insulin-treated diabetics. Laakso M, Sarlund H, Pyörälä K. Diabetes Res; 1987 Feb 07; 4(2):95-9. PubMed ID: 3581663 [Abstract] [Full Text] [Related]
19. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Reinehr T, Schober E, Wiegand S, Thon A, Holl R, DPV-Wiss Study Group. Arch Dis Child; 2006 Jun 07; 91(6):473-7. PubMed ID: 16449253 [Abstract] [Full Text] [Related]
20. Autoantibodies in children with type 2 diabetes mellitus. Umpaichitra V, Banerji MA, Castells S. J Pediatr Endocrinol Metab; 2002 Apr 07; 15 Suppl 1():525-30. PubMed ID: 12017227 [Abstract] [Full Text] [Related] Page: [Next] [New Search]